GSCLX
Price
$30.94
Change
-$0.09 (-0.29%)
Updated
Sep 20 closing price
RGAHX
Price
$75.98
Change
-$0.14 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

GSCLX vs RGAHX

Header iconGSCLX vs RGAHX Comparison
Open Charts GSCLX vs RGAHXBanner chart's image
Goldman Sachs Large Cap Gr Insghts Svc
Price$30.94
Change-$0.09 (-0.29%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R5E
Price$75.98
Change-$0.14 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GSCLX vs RGAHX Comparison Chart
Loading...
VS
GSCLX vs. RGAHX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSCLX is a Buy and RGAHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 290B vs. GSCLX (1.35B). RGAHX pays higher dividends than GSCLX: RGAHX (0.64) vs GSCLX (0.00). GSCLX was incepted earlier than RGAHX: GSCLX (27 years) vs RGAHX (9 years). GSCLX is a more actively managed with annual turnover of: 206.00 vs. RGAHX (31.00). GSCLX has a lower initial minimum investment than RGAHX: GSCLX (0) vs RGAHX (250). GSCLX annual gain was more profitable for investors over the last year : 32.16 vs. RGAHX (30.34). RGAHX return over 5 years is better than : 54.03 vs. GSCLX (2.09).
GSCLXRGAHXGSCLX / RGAHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years9 years-
Gain YTD26.70521.860122%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.35B290B0%
Annual Yield % from dividends0.000.64-
Returns for 1 year32.1630.34106%
Returns for 3 years-32.120.79-4,085%
Returns for 5 years2.0954.034%
Returns for 10 years51.17N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PPTA8.760.16
+1.86%
Perpetua Resources Corp
YHGJ1.010.01
+1.01%
Yunhong Green CTI Ltd
ARQT10.150.01
+0.10%
Arcutis Biotherapeutics
MATX134.72-2.46
-1.79%
Matsons
CSGP77.36-1.93
-2.43%
CoStar Group